Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
申请人:Carter H. Percy
公开号:US20050054626A1
公开(公告)日:2005-03-10
The present application describes modulators of MCP-1 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
本申请描述了MCP-1的调节剂,化学式为(I):或其药用可接受的盐形式,用于预防哮喘、多发性硬化症、动脉粥样硬化和类风湿性关节炎。